Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Merck lowers prices of some drugs after Trump calls out industry
Yahoo/Reuters
Fri, 07/20/18 - 09:38 am
Merck
drug pricing
Donald Trump
hepatitis C
Is Roche's latest Tecentriq win really a win for Merck's Keytruda?
Fierce Pharma
Thu, 07/19/18 - 11:14 am
Roche
immuno-oncology
Tecentriw
Merck
Keytruda
non-small cell lung cancer
Urovant seeks $150M IPO just a year after launch
Fierce Biotech
Mon, 07/16/18 - 10:16 pm
Urovant Sciences
IPOs
Merck
Roivant
overactive bladder
FDA Limits the Use of Tecentriq and Keytruda
RAPS.org
Wed, 07/4/18 - 11:25 am
FDA
Roche
Merck
Tecentriq
Keytruda
metastatic urothelial cancer
FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer
CP Wire
Mon, 07/2/18 - 09:21 am
Merck
Keytruda
non-small cell lung cancer
metastatic squamous non-small cell lung cancer
priority review
FDA
FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer
Mon, 07/2/18 - 09:16 am
Merck
Keytruda
squamous cell non-small cell lung cancer
Novo Nordisk trumpets more Januvia-topping data for oral semaglutide
Fierce Pharma
Fri, 06/29/18 - 10:20 am
Novo Nordisk
semaglutide
Merck
Januvia
HbA1C
U.S. Supreme Court to hear Merck appeal over Fosamax suits
Reuters
Thu, 06/28/18 - 07:26 pm
Merck
Fosamax
Supreme Court
Merck has hardened its defenses against cyberattacks like the one last year that cost it nearly $1B
Fierce Pharma
Thu, 06/28/18 - 07:18 pm
Merck
cyberattack
cybersecurity
Amgen Announces Top-Line Data From Remicade Biosimilar Study
Yahoo/Zacks.com
Thu, 06/28/18 - 09:34 am
Amgen
ABP 710
JNJ
Merck
Remicade
biosimilars
rheumatoid arthritis
AstraZeneca, Merck eye wider cancer drug use after study success
Yahoo/Reuters
Wed, 06/27/18 - 09:42 am
AstraZeneca
Merck
Lynparza
ovarian cancer
Merck & Co. could try to acquire Elanco (13.5bn)
GoinPharma
Sat, 06/23/18 - 01:13 pm
Merck
animal health
Elanco
M&A
Eli Lilly
HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women
Xtalks
Sat, 06/23/18 - 01:10 pm
vaccines
HPV
cervical cancer
Gardasil
Merck
Denmark
FDA limits first-line bladder cancer labels for Keytruda, Tecentriq
Biopharma Dive
Fri, 06/22/18 - 12:13 pm
FDA
Merck
Keytruda
Roche
Tecentriq
bladder cancer
Bristol-Myers clears another hurdle in Merck lung cancer showdown — but big challenges remain
Endpoints
Fri, 06/22/18 - 09:57 am
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
Fierce Pharma
Thu, 06/21/18 - 10:58 pm
Novo Nordisk
diabetes
semaglutide
Victoza
Merck
Januvia
Merck's Keytruda snags I-O's first cervical cancer nod to back up HPV fighter Gardasil
Fierce Pharma
Wed, 06/13/18 - 11:56 am
Merck
Keytruda
FDA
cervical cancer
Merck rebuts petition urging SCOTUS to ignore Fosamax appeal
Fierce Pharma
Tue, 06/12/18 - 10:27 pm
Merck
Fosamax
Supreme Court
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
Fierce Pharma
Tue, 06/12/18 - 11:22 am
GSK
Merck
Sanofi
Pfizer
Novavax
vaccines
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
Fierce Pharma
Fri, 06/8/18 - 09:48 am
Humira
AbbVie
Keytruda
Merck
Revlimid
Celgene
Opdivo
Bristol-Myers Squibb
Pages
« first
‹ previous
…
56
57
58
59
60
61
62
63
64
…
next ›
last »